Efficacy and Safety of Once-Daily Oral Sodium-Glucose Co-Transporter-2-Inhibitor Velagliflozin Compared to Twice-Daily Insulin Injection Therapy in Diabetic Cats - Niessen, S JM; Kooistra, H S; Forcada, Y (J Vet Intern Med, 2024)
[online ahead of print].